Sanofi-Aventis (France), Daiichi Sankyo Co Ltd. Delay Japan’s First Imported Vaccine

October 1, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Sept. 30 (Bloomberg) -- Sanofi-Aventis SA and Daiichi Sankyo Co. delayed plans to sell the first imported vaccine in Japan because it's taking longer than expected to make the product meet the country's standards.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory Asia

Sanofi (France) Daiichi Sankyo